Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

SCH79797

Copy Product Info
🥰Excellent
Catalog No. T28734Cas No. 245520-69-8
Alias SCH-79797, SCH 79797

SCH79797 is a potent and specific protease-activated receptor 1 (PAR1) antagonist with an IC50=70 nM with antimicrobial, anticancer, anti-inflammatory, and neuroprotective effects that attenuates thrombin-induced increase in CH25H expression in astrocytes, inhibits peritoneal dissemination of gastric cancer, and attenuates repetitive traumatic brain injury.

SCH79797

SCH79797

Copy Product Info
🥰Excellent
Purity: 99.80%
Catalog No. T28734Alias SCH-79797, SCH 79797Cas No. 245520-69-8
SCH79797 is a potent and specific protease-activated receptor 1 (PAR1) antagonist with an IC50=70 nM with antimicrobial, anticancer, anti-inflammatory, and neuroprotective effects that attenuates thrombin-induced increase in CH25H expression in astrocytes, inhibits peritoneal dissemination of gastric cancer, and attenuates repetitive traumatic brain injury.
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Add to Quotation
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.80%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
SCH79797 is a potent and specific protease-activated receptor 1 (PAR1) antagonist with an IC50=70 nM with antimicrobial, anticancer, anti-inflammatory, and neuroprotective effects that attenuates thrombin-induced increase in CH25H expression in astrocytes, inhibits peritoneal dissemination of gastric cancer, and attenuates repetitive traumatic brain injury.
Targets&IC50
PAR1:70 nM, PAR1:35 nM ( ki)
In vivo
Methods: SCH79797 (2.5, 10, 25, 50, 100 and 250 μg/kg, intravenously) was administered to rats and subjected to 30 min of ischemia and 180 min of reperfusion to investigate its cardioprotective effects in vivo.
Results: Infarct size, expressed as a percentage of area at risk (AAR), was 62 ± 3 % of the AAR in the control group; no significant changes in infarct size were observed at the lowest (2.5 μg/kg) and highest (250 μg/kg) doses of SCH79797; however, a gradual decrease was observed at doses of 10-100 μg/kg, with 25 μg/kg being the most effective dose. [1]
SynonymsSCH-79797, SCH 79797
Chemical Properties
Molecular Weight371.48
FormulaC23H25N5
Cas No.245520-69-8
SmilesN=1C(=NC2=CC=C3C(C=CN3CC4=CC=C(C=C4)C(C)C)=C2C1N)NC5CC5
Relative Density.1.32 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 40 mg/mL (107.68 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.38 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.6919 mL13.4597 mL26.9193 mL134.5967 mL
5 mM0.5384 mL2.6919 mL5.3839 mL26.9193 mL
10 mM0.2692 mL1.3460 mL2.6919 mL13.4597 mL
20 mM0.1346 mL0.6730 mL1.3460 mL6.7298 mL
50 mM0.0538 mL0.2692 mL0.5384 mL2.6919 mL
100 mM0.0269 mL0.1346 mL0.2692 mL1.3460 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy SCH79797 | purchase SCH79797 | SCH79797 cost | order SCH79797 | SCH79797 chemical structure | SCH79797 in vivo | SCH79797 formula | SCH79797 molecular weight